JAGUAR HEALTH, INC. Increase (Decrease) in Other Current Assets
JAGUAR HEALTH, INC. (JAGX) reported Increase (Decrease) in Other Current Assets of $122.16 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2016-05-10
- JAGUAR HEALTH, INC. increase (decrease) in other current assets for the quarter ending 2015-12-31 was $0.00.
- JAGUAR HEALTH, INC. increase (decrease) in other current assets for the quarter ending 2015-09-30 was $0.00.
- JAGUAR HEALTH, INC. increase (decrease) in other current assets for the quarter ending 2015-06-30 was $133.35K.
- JAGUAR HEALTH, INC. increase (decrease) in other current assets for the quarter ending 2015-03-31 was -$11.19K.
- JAGUAR HEALTH, INC. increase (decrease) in other current assets for fiscal 2015 was $122.16K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 3 month as first filed | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $0.00 derived: sum of 2 quarters · filed 2016-03-29 | $133.35K derived: sum of 3 quarters · filed 2016-03-29 | $122.16K 10-K · filed 2016-03-29 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $133.35K derived: sum of 2 quarters · filed 2015-11-13 | $122.16K 10-Q · filed 2015-11-13 | ||
| 2015-06-30 | $133.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $122.16K 10-Q · filed 2015-08-13 | |||
| 2015-03-31 | -$11.19K 10-Q · filed 2016-05-10 | $11.19K 10-Q · filed 2015-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |